Cervical cancer is a major worldwide health problem. Therefore, regular cervical screening in order to make an early diagnosis can help to prevent cervical cancer, through identifying and treating preinvasive cervical lesions. The aim of this review is to evaluate the correlation between the cytological screening result and the final gold standard histological outcome in the diagnosis of cervical lesions. More specifically, the correlation between high-grade intraepithelial lesion (HSIL) on cytology and histological cervical intraepithelial neoplasia grade 2 or higher (CIN2+) was intended, by calculating the positive predictive value (PPV). PPV is an important value from a clinical point of view. An electronic search was carried out in the electronic databases MEDLINE (through PubMed) and the Cochrane Library (last searched beginning of December 2017), supplemented with the related article feature in PubMed and snowballing. Article selection (predefined inclusion and exclusion criteria) and data extraction were evaluated by two independent reviewers (N.K. and A.V.L.). After identifying 1,146 articles, 27 articles were finally included in this systematic review, representing 28,783 cytological HSIL diagnoses in total. The PPV of HSIL was 77.5% (range: 45.4–95.2%) for the histological diagnosis of CIN2+ and 55.4% (range: 36.4–67.6%) for the diagnosis of CIN3+. In this systematic review, 77.5% of the HSIL-positive women eventually had a CIN2+ diagnosis. The diagnostic value of a cytological HSIL result (conventional or liquid-based cytology) in the diagnosis of CIN2+ lesions is good, but a combination of tests could raise this value.

1.
Ferlay
J
,
Soerjomataram
I
,
Dikshit
R
,
Eser
S
,
Mathers
C
,
Rebelo
M
, et al
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
.
Int J Cancer
.
2015
Mar
;
136
(
5
):
E359
86
.
[PubMed]
0020-7136
2.
WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva: World Health Organization
2013
.; 2013.
3.
McGoogan
E
.
Liquid-based cytology: the new screening test for cervical cancer control
.
J Fam Plann Reprod Health Care
.
2004
Apr
;
30
(
2
):
123
5
.
[PubMed]
1471-1893
4.
Wilbur
DC
,
Nayar
R
. Bethesda 2014: improving on a paradigm shift. Cytopathology : official journal of the British Society for Clinical Cytology.
2015
;26(6):339-42.
5.
Ingkapairoj
N
,
Luanratanakorn
S
,
Chumworathayi
B
,
Kietpeerakool
C
,
Supoken
A
.
Incidences of cervical intraepithelial neoplasia 2-3 or cancer pathologic diagnoses in patients with a high grade squamous intraepithelial lesion pap smear attending a colposcopy clinic at srinagarind hospital
.
Asian Pac J Cancer Prev
.
2012
;
13
(
12
):
6203
6
.
[PubMed]
1513-7368
6.
Walker
JL
,
Wang
SS
,
Schiffman
M
,
Solomon
D
;
ASCUS LSIL Triage Study Group
.
Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS)
.
Am J Obstet Gynecol
.
2006
Aug
;
195
(
2
):
341
8
.
[PubMed]
0002-9378
7.
Scholten
RJ
,
Offringa
M
,
Assendelft
WJ
. In: Amsterdam/Toronto/Nijmegen m, editor. Inleiding in evidence-based medicine. Houten: Bohn Stafleu van Loghum;
2014
. p. 38.
8.
Sacks
D
.
Age limits and adolescents
.
Paediatr Child Health
.
2003
Nov
;
8
(
9
):
577
8
.
[PubMed]
1205-7088
9.
Agramunt
S
,
Checa
MA
,
González-Comadrán
M
,
Larrazabal
F
,
Arbós
A
,
Alameda
F
, et al
High-grade squamous intraepithelial lesion could be managed conservatively in women up to 25 years: results from a retrospective cohort study
.
J Low Genit Tract Dis
.
2013
Oct
;
17
(
4
):
459
62
.
[PubMed]
1089-2591
10.
Kinney
W
,
Hunt
WC
,
Dinkelspiel
H
,
Robertson
M
,
Cuzick
J
,
Wheeler
CM
;
New Mexico HPV Pap Registry Steering Committee
.
Cervical excisional treatment of young women: a population-based study
.
Gynecol Oncol
.
2014
Mar
;
132
(
3
):
628
35
.
[PubMed]
0090-8258
11.
Massad
LS
,
Collins
YC
,
Meyer
PM
.
Biopsy correlates of abnormal cervical cytology classified using the Bethesda system
.
Gynecol Oncol
.
2001
Sep
;
82
(
3
):
516
22
.
[PubMed]
0090-8258
12.
Cetiner
H
,
Kır
G
,
Kaygusuz
E
,
Sağlıcan
Y
,
Kabaca
C
.
Is the low-grade squamous intraepithelial lesion/atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion category associated with cervical intraepithelial neoplasia 2?
Acta Cytol
.
2013
;
57
(
6
):
581
4
.
[PubMed]
0001-5547
13.
Insinga
RP
,
Glass
AG
,
Rush
BB
.
Diagnoses and outcomes in cervical cancer screening: a population-based study
.
Am J Obstet Gynecol
.
2004
Jul
;
191
(
1
):
105
13
.
[PubMed]
0002-9378
14.
Kingnate
C
,
Tangjitgamol
S
,
Khunnarong
J
,
Manusirivithaya
S
.
Abnormal uterine cervical cytology in a large tertiary hospital in Bangkok metropolis: Prevalence, management, and outcomes
.
Indian J Cancer
.
2016
Jan-Mar
;
53
(
1
):
67
73
.
[PubMed]
0019-509X
15.
Pan
QJ
,
Hu
SY
,
Zhang
X
,
Ci
PW
,
Zhang
WH
,
Guo
HQ
, et al
Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China
.
Cancer Cytopathol
.
2013
Sep
;
121
(
9
):
473
82
.
[PubMed]
1934-662X
16.
Saayman
F
,
Van Gelderen
CJ
,
Michelow
P
,
Van Den Berg
EJ
,
Adam
Y
.
Effect of 2 referral intervals on diagnostic discordance between cytology and histology at a colposcopy clinic
.
Int J Gynaecol Obstet
.
2013
Mar
;
120
(
3
):
257
61
.
[PubMed]
0020-7292
17.
Türkmen
IC
,
Başsüllü
N
,
Korkmaz
P
,
Günenç
B
,
Baykal
CM
,
Güdücü
N
, et al
Patients with epithelial cell abnormality in PAP smears: correlation of results with follow-up smears and cervical biopsies
.
Turk Patoloji Derg
.
2013
;
29
(
3
):
179
84
.
[PubMed]
1018-5615
18.
Zhang
M
,
Carrozza
M
,
Huang
Y
.
Correlation discrepancies between high-grade squamous intraepithelial lesions and high-grade cervical intraepithelial neoplasia: a cytological/histological correlation study from a single-institution experience
.
Acta Cytol
.
2014
;
58
(
1
):
47
52
.
[PubMed]
0001-5547
19.
Kinney
WK
,
Manos
MM
,
Hurley
LB
,
Ransley
JE
.
Where’s the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses
.
Obstet Gynecol
.
1998
Jun
;
91
(
6
):
973
6
.
[PubMed]
0029-7844
20.
Numnum
TM
,
Kirby
TO
,
Leath
CA
 3rd
,
Huh
WK
,
Alvarez
RD
,
Straughn
JM
 Jr
.
A prospective evaluation of “see and treat” in women with HSIL Pap smear results: is this an appropriate strategy?
J Low Genit Tract Dis
.
2005
Jan
;
9
(
1
):
2
6
.
[PubMed]
1089-2591
21.
Massad
LS
,
Behbakht
K
,
Collins
YC
,
Cejtin
HE
.
Histologic findings from the cervix among older women with abnormal cervical cytology
.
Gynecol Oncol
.
2003
Mar
;
88
(
3
):
340
4
.
[PubMed]
0090-8258
22.
Benedet
JL
,
Matisic
JP
,
Bertrand
MA
.
An analysis of 84244 patients from the British Columbia cytology-colposcopy program
.
Gynecol Oncol
.
2004
Jan
;
92
(
1
):
127
34
.
[PubMed]
0090-8258
23.
Aue-Aungkul
A
,
Punyawatanasin
S
,
Natprathan
A
,
Srisomboon
J
,
Kietpeerakool
C
.
“See and treat” approach is appropriate in women with high-grade lesions on either cervical cytology or colposcopy
.
Asian Pac J Cancer Prev
.
2011
;
12
(
7
):
1723
6
.
[PubMed]
2476-762X
24.
Sankaranarayanan
R
,
Thara
S
,
Sharma
A
,
Roy
C
,
Shastri
S
,
Mahé
C
, et al;
Multicentre Study Group on Cervical Cancer Early Detection in India
.
Accuracy of conventional cytology: results from a multicentre screening study in India
.
J Med Screen
.
2004
;
11
(
2
):
77
84
.
[PubMed]
0969-1413
25.
Kashimura
M
,
Matsuura
Y
,
Kawagoe
T
,
Toki
N
,
Hachisuga
T
.
New diagnostic criteria of colposcopy for uterine cervix neoplasia
.
J Obstet Gynaecol Res
.
2017
Feb
;
43
(
2
):
339
44
.
[PubMed]
1341-8076
26.
Hoo
SS
,
Patel
A
,
Buist
H
,
Galaal
K
,
Hemming
JD
,
Naik
R
.
Borderline nuclear change, high-grade dyskaryosis not excluded: current concepts and impact on clinical practice.
Cytopathology : official journal of the British Society for Clinical Cytology.
2012
;23(6):396-401.
27.
Sorbye
SW
, P S, BW R, J B, RJ M, K A-S. - Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by. BMC Clin Pathol.
2017
;17(18):017-0058.
28.
Berdichevsky
L
,
Karmin
R
,
Chuang
L
.
Treatment of high-grade squamous intraepithelial lesions: a 2- versus 3-step approach
.
Am J Obstet Gynecol
.
2004
May
;
190
(
5
):
1424
6
.
[PubMed]
0002-9378
29.
Boonlikit
S
.
Prevalence of high-grade cervical lesion in women with LSIL and HSIL cytology and prevalence of invasive cancer in women cytologically positive for malignancy
.
Asian Pac J Cancer Prev
.
2008
Oct-Dec
;
9
(
4
):
715
8
.
[PubMed]
2476-762X
30.
Kabaca
C
,
Sariibrahim
B
,
Keleli
I
,
Karateke
A
,
Cesur
S
,
Cetiner
H
.
The importance of immediate verification of a cervical cytological abnormality with histology
.
Indian J Cancer
.
2013
Oct-Dec
;
50
(
4
):
292
6
.
[PubMed]
0019-509X
31.
Kantathavorn
N
,
Phongnarisorn
C
,
Srisomboon
J
,
Suprasert
P
,
Siriaunkgul
S
,
Khunamornpong
S
, et al
Northern Thai women with high grade squamous intraepithelial lesion on cervical cytology have high prevalence of underlying invasive carcinoma
.
Asian Pac J Cancer Prev
.
2006
Jul-Sep
;
7
(
3
):
477
9
.
[PubMed]
1513-7368
32.
Kuperman
NS
,
Russomano
FB
,
de Melo
YL
,
Gomes
SC
 Jr
.
Preinvasive and invasive disease in women with cytological diagnosis of high-grade lesion and high-grade lesion cannot exclude microinvasion
.
BMC Womens Health
.
2015
Oct
;
15
(
1
):
81
.
[PubMed]
1472-6874
33.
Poomtavorn
Y
,
Himakhun
W
,
Suwannarurk
K
,
Thaweekul
Y
,
Maireang
K
.
Cytohistologic discrepancy of high-grade squamous intraepithelial lesions in Papanicolaou smears
.
Asian Pac J Cancer Prev
.
2013
;
14
(
1
):
599
602
.
[PubMed]
1513-7368
34.
Demirkiran
F
,
Kahramanoglu
I
,
Turan
H
,
Yilmaz
N
,
Yurtkal
A
,
Meseci
E
, et al
See and treat strategy by LEEP conization in patients with abnormal cervical cytology
.
Ginekol Pol
.
2017
;
88
(
7
):
349
54
.
[PubMed]
0017-0011
35.
Kietpeerakool
C
,
Tangjitgamol
S
,
Srisomboon
J
.
Histopathological outcomes of women with abnormal cervical cytology: a review of literature in Thailand
.
Asian Pac J Cancer Prev
.
2014
;
15
(
16
):
6489
94
.
[PubMed]
1513-7368
36.
Arbyn
M
,
Depuydt
C
,
Benoy
I
,
Bogers
J
,
Cuschieri
K
,
Schmitt
M
, et al
VALGENT: A protocol for clinical validation of human papillomavirus assays.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
2016
;76 Suppl 1:S14-21.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.